Urokinase is required for T lymphocyte proliferation and activation in vitro

Journal of Laboratory and Clinical Medicine

Volumn 133, Issue 3, 1999, Pages 274-288

  Gyetko, Margaret R ^a,b   Libre, Eric A ^a   Fuller, Jennifer A ^a   Chen, Gwo Hsiao ^a   Toews, Galen B ^a  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033105351     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90084-7     Document Type: Article

References (55)

1. 1. Estreicher A, Mühlhause J, Carpentier J, Orci L, Vassalli J. The receptor for urokinase type plasminogen activator polarises expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol 1990;111:783-92.
2. 2. Gyetko MR, Todd RF III, Wilkinson CC, Sitrin RG. The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest 1994;93:1380-7.
3. 3. Gyetko MR, Sitrin RG, Fuller JA, Todd RF III, Petty H, Standiford TJ. Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J Leukocyte Biol 1995;58:533-8.
4. 4. Gyetko MR, Chen G-H, McDonald RA, et al. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans: a murine transgenic model. J Clin Invest 1996;97:1818-26.
5. 5. Kirchheimer JC, Remold HG. Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors. Blood 1989;74:1396-402.
6. 6. Kirchheimer JC, Remold HG. Endogenous receptor-bound urokinase mediates tissue invasion of human monocytes. J Immunol 1989;143:2634-9.
7. 7. Saksela O, Hovi T, Vaheri A. Urokinase-type plasminogen activator and its inhibitor secreted by cultured human monocyte-macrophages. J Cell Physiol 1985;122;125-32.
8. 8. Vassalli JD, Dayer JM, Wohlwend A, Belin D. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages. J Exp Med 1984;159:1653-68.
9. 9. Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989;321:794-9.
10. 10. Huffnagle GB, Yates JL, Lipscomb MF. T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect Immun 1991;59:1423-33.
11. 11. Huffnagle GB, Yates JL, Lipscomb MF. Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells. J Exp Med 1991;173:793-800.
12. 12. Carmeliet P, Schoonjans L, Kieckens L, et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994;368:419-24.
13. 13. Degen SJF, Heckel JL, Reich E, Degen JL. The murine urokinase-type plasminogen activator gene. Biochemistry 1987;26:8270-9.
14. 14. Turka LA, Goodman RE, Rutkowski JL, et al. IL-12: a potential link between nerve cells and the immune system. Mol Med 1995;1:690-9.
15. 15. Shapiro RL, Duquette JG, Nunes I, et al. Animal model: urokinase-type plasminogen activator-deficient mice are predisposed to staphylococcal botryomycosis, pleuritis, and effacement of lymphoid follicles. Am J Pathol 1997;150:359-69.
16. 16. Stobo JD. Phytohemagglutin and concanavalin A: probes for murine T cell activation and differentiation. Transplant 1972;11:60-86.
17. 17. Gyetko M, Shollenberger S, Sitrin R. Urokinase expression in mononuclear phagocytes: cytokine-specific modulation by interferon gamma and tumor necrosis factor-alpha. J Leukocyte Biol 1992;51:256-63.
18. 18. Gyetko MR, Wilkinson CC, Sitrin RG. Monocyte urokinase expression: modulation by interleukins. J Leukocyte Biol 1993;53:598-601.
19. 19. Abbas AK, Pober JS, Lichtman AH, editors. Cellular and molecular immunology. Philadelphia: WB Saunders; 1994.
20. 20. Murphy JA. Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response. Infect Immun 1993;61:4750-9.
21. 21. Colle J-H, Saron M-F, Bachi PT. Altered cytokine gene expression by Con A -activated spleen cells from mice infected by lymphocytic choriomeningitis virus. Immunol Lett 1993;35:247-53.
22. 22. Szamel M, Resch K. T-cell antigen receptor-induced signal-transduction pathways. Activation and function of protein kinases C in T lymphocytes. Eur J Biochem 1995;228:1-15.
23. 23. Stobo JD. Lymphocytes: T cells. In: Stites DP, Stobo JD, Wells JV, editors. Basic and clinical immunology. 6th ed. Norwalk, CT: Appelton & Lange; 1987. p. 65-74.
24. 24. Nusrat A, Chapman H. An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. J Clin Invest 1991;87:1091-7.
25. 25. Wilson W, Francis G. Differentiation-linked secretion of urokinase and tissue plasminogen activator by normal human hemopoietic cells. J Exp Med 1987;165:1609-23.
26. 26. Bianchi E, Ferrero E, Fazioli F, et al. Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes. J Clin Invest 1996;98:1133-41.
27. 27. Gunderson D, Tran-Thang C, Sordat B, Mourali F, Ruegg C. Plasmin-induced proteolysis of Tenascin-C. Modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering. J Immunol 1997;158:1051-60.
28. 2K. Nykjaer A, Miller B, Todd RF III, et al. Urokinase receptor: an activation antigen in human T lymphocytes. J Immunol 1994;152:505-16.
29. 29. Favero JJ, Gordon IL, Parker JW, O'Brien RL. Lymphocyte receptors for polyclonal T mitogens. II. High-molecular-weight glycoproteins are the best candidate sites for mitogenic action by concanavalin A and galactose oxidase. Cell Immunol 1982;68:38-52.
30. 30. Gerhart S, Mills G, Monticone V, Paetkau V. Quantitative analysis of the proliferate activity induced in murine thymocytes by concanavalin A. J Immunol 1976;117:1314-9.
31. 31. Nilsson SF, Waxdal MJ. Isolation and identification of the major concanavalin A binding glycoproteins from murine lymphocytes. Biochemistry 1976;15:2698-705.
32. 32. Stobo JD, Paul WE. Functional heterogeneity of murine lymphoid cells. Acquisition of mitogen responsiveness and of 0 antigen during the ontogeny of thymocytes and T lymphocytes. Cell Immunol 1972;4:367-80.
33. 33. Golub ES. Immunology: a synthesis. Sunderland: Sinauer Associates; 1987.
34. 34. Asao H, Tanaka N, Ishii N, et al. Interleukin 2-induced activation of JAK3: possible involvement in signal transduction for c-myc induction and cell proliferation. FEBS Lett 1994;351:201-6.
35. 35. Jenkins MK. Models of lymphocyte activation. The role of cell division in the induction of clonal anergy. Immunol Today 1992;13:69-73.
36. 36. Jenkins MK, Johnson JG. Molecules involved in T-cell costimulation. Curr Opin Immunol 1993;5:361-7.
37. 37. Ricard I, Payet MD, Dupuis G. Clustering the adhesion molecules VLA-4 (CD49d/CD29) in Jurkat T cells of VCAM-1 (CD106) in endothelial (ECV 304) cells activates the phosphoinositide pathway and triggers Ca++ mobilization. Eur J Immunol 1997;27:1530-8.
38. β1 (CD49d/CD29) integrin costimulation of human T cells enhances transcription factor and cytokine induction in the absence of altered sensitivity to anti-CD3 stimulation. J Immunol 1996;157:1965-72.
39. 39. Testi R, Phillips JH, Lanier LL. T cell activation via Leu-23 (CD69). J Immunol 1989;143:1123-8.
40. 40. Tugores A, Alonso MA, Sanchez-Madrid F, de Landazuri MO. Human T cell activation through the activation-inducer molecule/CD69 inhances the activity of transcription factor AP-1. J Immunol 1992;148:2300-6.
41. 41. Santis AG, Lopez-Cabrera M, Sanchez-Madrid F, Proudfoot N. Expression of the early lymphocyte activation antigen CD69, a C-type lectin, is regulated by mRNA degradation associated with AU-rich sequence motifs. Eur J Immunol 1995;25:2142-6.
42. 42. Risso A, Smilovich D, Capra MC, et al. CD69 in resting and activated T lymphocytes. Its association with a GTP binding protein and biochemical requirements for its expression. J Immunol 1991;146:4105-14.
43. 43. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-33.
44. 44. Turunen JP, Mattila P, Halttunen J, Hayry P, Renkonen R. Evidence that lymphocyte traffic into rejecting cardiac allografts is CD1 la-and CD49d-dependent. Transplantation 1992;54:1053-8.
45. 45. Bednarczyk JL, Teague TK, Wygant JN, Davis LS, Lipsky PE, McIntyre BW. Regulation of T cell proliferation by anti-CD49d and anti-CD29 monoclonal antibodies. J Leukocyte Biol 1992;52:456-62.
46. 46. Brunda MJ. Interleukin-12. J Leukocyte Biol 1994;55:280-8.
47. 47. Hoag KA, Lipscomb MF, Izzo AA, Street NE. IL-12 and IFN-γ are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am J Respir Cell Mol Biol 1997;17:733-9.
48. 48. Scott P, Kaufmann SHE. The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today 1991;12:346-8.
49. 49. Keane-Myers AM, Gause WC, Finkelman FD, Xhou X-D, Wills-Karp M. Development of murine allergic asthma is dependent upon B7-2 costimulation. J Immunol 1998;160:1036-43.
50. 50. Reiner SL, Locksley RM. The regulation of immunity of Leishmania major. Annu Rev Immunol 1995;13:151.
51. 51. Romani L, Menacacci A, Cenci E, et al. CD4+ subset expression in murine candidiasis. J Immunol 1993;150:925.
52. 52. Manetti R, Parronchi P, Giudizi MG, et al. Natural killer cell stimulatory factor (interleukin 12) induced T helper type 1 (Th1)-specific immune response and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:1199-204.
53. 53. Fiorentino DF, Zlotnik A, Vieira P, et al. IL-10 acts on the antogen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991;146:3444-51.
54. 54. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95.
55. 55. Wada H, Noguchi Y, Marino MW, Dunn AR, Old LJ. T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice. Proc Natl Acad Sci 1997;94:12557-61.